Publications by authors named "M Yu Akimov"

Endocannabinoid anandamide (AEA) and paracannabinoid lysophosphatidylinositol (LPI) play a significant role in cancer cell proliferation regulation. While anandamide inhibits the proliferation of cancer cells, LPI is known as a cancer stimulant. Despite the known endocannabinoid receptor crosstalk and simultaneous presence in the cancer microenvironment of both molecules, their combined activity has never been studied.

View Article and Find Full Text PDF

The purpose of this work was to study the qualitative and quantitative composition of the main groups of biologically active substances in the fresh fruits of five different varieties of black chokeberry ( (Michx.) Elliot), carried out within the framework of the search for available and cost-effective raw materials for food product fortification. Samples of aronia chokeberry were grown at the Federal Scientific Center named after I.

View Article and Find Full Text PDF

Despite the wide variety of available cationic lipid platforms for the delivery of nucleic acids into cells, the optimization of their composition has not lost its relevance. The purpose of this work was to develop multi-component cationic lipid nanoparticles (LNPs) with or without a hydrophobic core from natural lipids in order to evaluate the efficiency of LNPs with the widely used cationic lipoid DOTAP (1,2-dioleoyloxy-3-[trimethylammonium]-propane) and the previously unstudied oleoylcholine (Ol-Ch), as well as the ability of LNPs containing GM3 gangliosides to transfect cells with mRNA and siRNA. LNPs containing cationic lipids, phospholipids and cholesterol, and surfactants were prepared according to a three-stage procedure.

View Article and Find Full Text PDF

GPR55 is a non-canonical cannabinoid receptor, important for cancer proliferation. Depending on the ligand, it induces either cell proliferation or death. The objective of the study was to establish the mechanisms of this multidirectional signaling.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on creating co-delivery systems using paclitaxel and a prodrug of etoposide, utilizing human serum albumin (HSA) and poly(lactide-co-glycolide) nanoparticles.
  • The nanoparticles were analyzed for various properties and demonstrated sizes of 90-150 nm, showing effective cytotoxicity against glioma cells, particularly Neuro2A cells.
  • The results indicated a synergistic effect of the drug combinations, suggesting these delivery systems could enhance chemotherapy treatments for brain tumors, marking a novel approach using HSA-based formulations.
View Article and Find Full Text PDF